Specific bronchial hyperreactivity and hypersensitivity in patients with allergic asthma
Abstract
Background/Aim. Bronchial asthma is a disease that is characterized by the variability of the clinical picture, physical and functional status and the existence of bronchial hypersensitivity and hyperreactivity with varying degrees. Bronchial responsiveness and sensitivity are tested in patients with clinically suspected existence of asthma and normal spirometry test. The aim of the study was to analyze the patients with atopic asthma and study test results of skin sensitization to inhaled allergens, nonspecific bronchial hyperreactivity and specific hyperreactivity estimated by bronchial provocation tests with inhalant allergens. Methods. The prospective study at the Pulmonology Clinic of the Military Medical Academy in Belgrade Serbia, during 2014, included 70 male subjects aged 18–30 years, who had perennial asthma symptoms. All subjects were nonsmokers, with normal spirometry findings, with normal radiological chest findings and with no symptoms of respiratory infection over the past two months. All respondents were tested with skin prick tests with inhalant allergens and nonspecific bronchial provocation test with histamine. On the basis of histamine test, subjects were divided into two groups: the group I, in which there was a slight degree of hypersensitivity [provocation concentration of histamine causing a 20% fall in forced expiratory volume – PC20 = 6.09 ± 1.1 mg/mL], and the group II with negative histamine test (PC20 = 14.58 ± 6.34 mg/mL). Specific bronchial provocation test was performed in all patients, and the selection of the allergens was carried out based on the results of testing of skin hypersensitivity. Results. Results of skin sensitization show the highest incidence of mites Dermatophagoides pterronissinus (83.3% group I and 85.0% group II) followed by grass pollen (53.3% group I and 52.0% group II), and house dust (33.3% group I and 50.0% group II). There were no statistically significant differences in allergens between groups (p > 0.05). In both groups, spirometry findings were within normal values [forced vital capacity – FVC and forced expiratory volume 1 – FEV1 > 80% predictive value], but statistically significant difference was found in FEV1 between groups (p < 0.05). Specific bronchial provocation tests with solutions of inhaled allergens in both groups caused a significant decline in FEV1 (≥ 20%) in all patients individually. No statistically significant differences were found neither between groups, nor between individual allergens (average decline in FEV1: Group I 32.9 ± 2.4% and group II 31.5 ± 2.2%). Conclusion. There is no relationship between the degree of specific and non-specific bronchial hyperreactivity in patients with allergic asthma.
References
Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. 2015. Available from: http://ginasthma.org/gina-report-global-strategy-for-asthma-management-and-prevention/
Worth A, Pinnock H, Fletcher M, Hoskins G, Levy ML, Sheikh A. Systems for the management of respiratory disease in primary care: An international series: United Kingdom. Prim Care Respir J 2011; 20(1): 23−32.
O'Byrne PM, Inman MD. Airway hyperresponsiveness. Chest 2003; 123(3Suppl): 411S−6S.
Borak J, Lefkowitz RY. Bronchial hyperresponsiveness. Occup Med (Lond) 2016; 66(2): 95−105.
Novković D, Skuletić V, Vulin A, Cvetković G. Exercise-induced bronchoconstriction and non-specific airway hyperreactivity in patients suffering from bronchial asthma. Vojnosanit Pregl 2014; 71(2): 191−4.
Cockcroft DW. Bronchoprovocation methods: Direct challeng-es. Clin Rev Allergy Immunol 2003; 24(1): 19−26.
Anderson SD. Provocative challenges to help diagnose and monitor asthma: Exercise, methacholine, adenosine, and man-nitol. Curr Opin Pulm Med 2008; 14(1): 39−45.
Anderson SD, Brannan JD. Bronchial provocation testing: The future. Curr Opin Allergy Clin Immunol 2011; 11(1): 46−52.
Zhong NS, Chen RC, Yang MO, Wu ZY, Zheng JP, Li YF. Is asymptomatic bronchial hyperresponsiveness an indication of potential asthma?, A two-year follow-up of young students with bronchial hyperresponsiveness. Chest 1992; 102(4): 1104−9.
Leuppi JD. Bronchoprovocation tests in asthma: Direct versus indirect challenges. Curr Opin Pulm Med 2014; 20(1): 31−6.
Katial RK, Covar RA. Bronchoprovocation testing in asthma. Immunol Allergy Clin North Am 2012; 32(3): 413−31.
Guan WJ, Zheng XY, Zheng JP, Boudewijn IM, Telenga ED, van der Wiel E, et al. Small airway dysfunction in asymptomatic bron-chial hyperresponsiveness and asthma. Allergy 2014; 69(9): 1258−9.
Ortega HG, Weissman DN, Carter DL, Banks D. Use of specific inhalation challenge in the evaluation of workers at risk for oc-cupational asthma: A survey of pulmonary, allergy, and occu-pational medicine residency training programs in the United States and Canada. Chest 2002; 121(4): 1323−8.
Alvarez-Puebla MJ, Olaguibel-Rivera JM, Urbiola-Marcilla E, Garcia BE, Tabar-Purroy AI. Determinants of allergen-induced late bronchial responses in mild asthmatics. Chest 2001; 119(1): 120−7.
Reddel HK, Levy ML. Global Initiative for Asthma Scientific Committee and Dissemination and Implementation Commit-tee. The GINA asthma strategy report: what's new for primary care? NPJ Prim Care Respir Med 2015; 25: 15050.
European Lung White Book. The economic burden of lung disease. The first comprehensive survey on respiratory lung health in Europe. Available from: http://www.erswhitebook.org/chapters/the-economic-burden-of-lung-disease/
Parkerson J, Ledford D. Mannitol as an indirect bronchoprovo-cation test for the 21st century. Ann Allergy Asthma Immunol 2011; 106(2): 91−6.
Farrokhi S, Gheybi MK, Movahed A, Tahmasebi R, Iranpour D, Fatemi A, et al. Common aeroallergens in patients with asthma and allergic rhinitis living in southwestern part of Iran: based on skin prick test reactivity. Iran J Allergy Asthma Immunol 2015; 14(2): 133−8.
Bazarbachi T, Haddad Y, Irani C, Salameh P, Khoury D, Khayat G, et al. Choosing the best panel of aeroallergen prick-tests for patients in Lebanon with rhinitis and asthma: A retrospective study of 2350 patients. Rev Mal Respir 2014; 31(9): 839−48.
Cockcroft DW, Ruffin RE, Frith PA, Cartier A, Juniper EF, Dolovich J,et al. Determinants of allergen-induced asthma: Dose of allergen, circulating IgE antibody concentration, and bronchial responsiveness to inhaled histamine. Am Rev Respir Dis 1979; 120(5): 1053−8.
Cockroft DN. Provocations tests. In: O'Byrne PM, Tompson NC, editors. Manual of asthma management. Philadelphia: Saun-ders Ltd; 1995. p. 120−31.
Boulet LP, Gauvreau G, Boulay ME, O'Byrne PM, Cockcroft DW. Allergen-induced early and late asthmatic responses to inhaled seasonal and perennial allergens. Clin Exp Allergy 2015; 45(11): 1647−53.
Sulakvelidze I, Inman MD, Rerecich T, O'Byrne PM. Increases in airway eosinophils and interleukin-5 with minimal broncho-constriction during repeated low-dose allergen challenge in atopic asthmatics. Eur Respir J 1998; 11(4): 821−7.
Djukanović R, Feather I, Gratziou C, Walls A, Peroni D, Bradding P, et al. Effect of natural allergen exposure during the grass pollen season on airways inflammatory cells and asthma symptoms. Thorax 1996; 51(6): 575−81.
Kurt E, Bavbek S, Aksu O, Erekul S, Misirligil Z. The effect of natural pollen exposure on eosinophil apoptosis and its rela-tionship to bronchial hyperresponsiveness in patients with seasonal allergic rhinitis. Ann Allergy Asthma Immunol 2005; 95(1): 72−8.